WBR0446: Difference between revisions
No edit summary |
m refreshing WBR questions |
||
(3 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor={{ | |QuestionAuthor= {{YD}} (Reviewed by Will Gibson) {{Alison}} (Reviewed by Serge Korjian) | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|MainCategory=Pathology | |MainCategory=Pathology | ||
Line 21: | Line 21: | ||
|MainCategory=Pathology | |MainCategory=Pathology | ||
|SubCategory=Endocrine | |SubCategory=Endocrine | ||
|Prompt=A 45-year-old | |Prompt=A 45-year-old woman presents to the physician’s office with complaints of severe diarrhea of several days duration. The patient’s medical history is significant for recurrent kidney stones and a parathyroidectomy 8 years ago. Her fasting gastrin level is elevated and endoscopy reveals multiple ulcers in the stomach, duodenum, and jejunum. Which of the following findings is most frequently associated with this patient's condition? | ||
|Explanation=The patient in this vignette most likely has | |Explanation=The patient in this vignette most likely has ''multiple endocrine neoplasia type 1'' (MEN 1). From the patient's past history of parathyroidectomy, it is highly likely that she had a parathyroid adenoma. Parathyroid adenomas classically secrete excessive PTH leading to elevated serum calcium and decreased serum phosphate levels. The increased serum calcium also leads to excess urinary excretion, increasing the risk of calcium oxalate kidney stones.<br> | ||
The | The current presentation is highly consistent with a gastrinoma, a gastrin-secreting tumor that arises from tissues of either the pancreas or the duodenal wall. Gastrin is a peptide hormone that stimulates parietal cells to increase gastric acid secretion. Patients with gastrinomas therefore frequently develop multiple ulcers due to excessive gastric acid production in the stomach. Nearly 25% of gastrinoma patients have MEN 1. A patient who has developed both parathyroid adenoma and gastrinoma is highly likely to be affected by MEN 1. [[MEN 1 syndrome]] is characterized by parathyroid tumors, pituitary tumors, and pancreatic endocrine tumors. Several subtypes of pancreatic endocrine tumors are associated with MEN 1, including gastrinoma, insulinoma, VIPoma, or glucagonoma. All of the MEN syndromes are dominantly inherited genetic disorders. MEN 1 syndrome is caused by mutations in the MEN1 gene that ecodes the tumor suppressor menin. | ||
[[MEN | |||
All of the MEN syndromes are dominantly inherited genetic disorders. | |||
A good way to remember which organ systems are affected by the different MEN syndromes is: | A good way to remember which organ systems are affected by the different MEN syndromes is: | ||
MEN | MEN 1 (3 Ps) - Pituitary, Parathyroid, Pancreatic | ||
MEN | MEN 2A (1M,2Ps) - Medullary Thyroid Ca, Pheochromocytoma, Parathyroid | ||
MEN | MEN 2B (2Ms,1P) - Medullary Thyroid Ca, Marfanoid habitus/mucosal neuroma, Pheochromocytoma | ||
|AnswerA=Oral ganglioneuroma | |AnswerA=Oral ganglioneuroma | ||
|AnswerAExp=Oral ganglioneuromatosis frequently occurs in patients with MEN2B syndrome. | |AnswerAExp=Oral ganglioneuromatosis frequently occurs in patients with MEN2B syndrome. | ||
Line 40: | Line 36: | ||
|AnswerCExp=Medullary thyroid cancer frequently occurs in MEN 2A and MEN 2B syndromes. | |AnswerCExp=Medullary thyroid cancer frequently occurs in MEN 2A and MEN 2B syndromes. | ||
|AnswerD=Prolactinoma | |AnswerD=Prolactinoma | ||
|AnswerDExp=Prolactinoma, a pituitary tumor, frequently occurs in MEN | |AnswerDExp=Prolactinoma, a pituitary tumor, frequently occurs in MEN 1 syndrome. | ||
|AnswerE=Carcinoid tumor | |AnswerE=Carcinoid tumor | ||
|AnswerEExp=Carcinoid tumor is an endocrine tumor, but is not frequently associated with MEN syndrome. | |AnswerEExp=Carcinoid tumor is an endocrine tumor, but is not frequently associated with MEN syndrome. | ||
|EducationalObjectives=MEN | |EducationalObjectives=MEN 1 syndrome often manifests with pituitary tumors, parathyroid tumors, or pancreatic endocrine tumors. | ||
|References=Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., ... & Brandi, M. L. (2012). Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). The Journal of Clinical Endocrinology & Metabolism, 97(9), 2990-3011.<br> | |References=Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., ... & Brandi, M. L. (2012). Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). The Journal of Clinical Endocrinology & Metabolism, 97(9), 2990-3011.<br> | ||
Basuroy R, Srirajaskanthan R, Prachalias A, Quaglia A, Ramage JK. Review article: the investigation and management of gastric neuroendocrine tumours. Aliment Pharmacol Ther. May 2014;39(10):1071-84.<br> | Basuroy R, Srirajaskanthan R, Prachalias A, Quaglia A, Ramage JK. Review article: the investigation and management of gastric neuroendocrine tumours. Aliment Pharmacol Ther. May 2014;39(10):1071-84.<br> |
Latest revision as of 00:35, 28 October 2020
Author | [[PageAuthor::Yazan Daaboul, M.D. (Reviewed by Will Gibson) (Reviewed by Alison Leibowitz) (Reviewed by Serge Korjian)]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Pathology |
Sub Category | SubCategory::Endocrine |
Prompt | [[Prompt::A 45-year-old woman presents to the physician’s office with complaints of severe diarrhea of several days duration. The patient’s medical history is significant for recurrent kidney stones and a parathyroidectomy 8 years ago. Her fasting gastrin level is elevated and endoscopy reveals multiple ulcers in the stomach, duodenum, and jejunum. Which of the following findings is most frequently associated with this patient's condition?]] |
Answer A | AnswerA::Oral ganglioneuroma |
Answer A Explanation | AnswerAExp::Oral ganglioneuromatosis frequently occurs in patients with MEN2B syndrome. |
Answer B | AnswerB::Pheochromocytoma |
Answer B Explanation | AnswerBExp::Pheochromocytoma frequently occurs in MEN 2A and MEN 2B syndromes. |
Answer C | AnswerC::Medullary thyroid cancer |
Answer C Explanation | AnswerCExp::Medullary thyroid cancer frequently occurs in MEN 2A and MEN 2B syndromes. |
Answer D | AnswerD::Prolactinoma |
Answer D Explanation | AnswerDExp::Prolactinoma, a pituitary tumor, frequently occurs in MEN 1 syndrome. |
Answer E | AnswerE::Carcinoid tumor |
Answer E Explanation | AnswerEExp::Carcinoid tumor is an endocrine tumor, but is not frequently associated with MEN syndrome. |
Right Answer | RightAnswer::D |
Explanation | [[Explanation::The patient in this vignette most likely has multiple endocrine neoplasia type 1 (MEN 1). From the patient's past history of parathyroidectomy, it is highly likely that she had a parathyroid adenoma. Parathyroid adenomas classically secrete excessive PTH leading to elevated serum calcium and decreased serum phosphate levels. The increased serum calcium also leads to excess urinary excretion, increasing the risk of calcium oxalate kidney stones. The current presentation is highly consistent with a gastrinoma, a gastrin-secreting tumor that arises from tissues of either the pancreas or the duodenal wall. Gastrin is a peptide hormone that stimulates parietal cells to increase gastric acid secretion. Patients with gastrinomas therefore frequently develop multiple ulcers due to excessive gastric acid production in the stomach. Nearly 25% of gastrinoma patients have MEN 1. A patient who has developed both parathyroid adenoma and gastrinoma is highly likely to be affected by MEN 1. MEN 1 syndrome is characterized by parathyroid tumors, pituitary tumors, and pancreatic endocrine tumors. Several subtypes of pancreatic endocrine tumors are associated with MEN 1, including gastrinoma, insulinoma, VIPoma, or glucagonoma. All of the MEN syndromes are dominantly inherited genetic disorders. MEN 1 syndrome is caused by mutations in the MEN1 gene that ecodes the tumor suppressor menin. A good way to remember which organ systems are affected by the different MEN syndromes is:
MEN 1 (3 Ps) - Pituitary, Parathyroid, Pancreatic
MEN 2A (1M,2Ps) - Medullary Thyroid Ca, Pheochromocytoma, Parathyroid
MEN 2B (2Ms,1P) - Medullary Thyroid Ca, Marfanoid habitus/mucosal neuroma, Pheochromocytoma |
Approved | Approved::Yes |
Keyword | WBRKeyword::Prolactinoma, WBRKeyword::Pheochromocytoma, WBRKeyword::Gastrinoma, WBRKeyword::Neoplasia, WBRKeyword::MEN I, WBRKeyword::Cancer, WBRKeyword::Wermer syndrome, WBRKeyword::Diarrhea, WBRKeyword::Ulcers, WBRKeyword::Gastrinoma, WBRKeyword::Tumor, WBRKeyword::Pancreatic cancer, WBRKeyword::Multiple endocrine neoplasia |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |